Jay M. Moyes, Director at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 22,000 shares at $7.22 ($159K) on 2026-06-12, disclosed to the SEC on 2026-06-15.
Scheduled sale ($159k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PBYI | SELL | 2025-06-17 | $75K | — | Filing → |
| PBYI | SELL | 2024-06-17 | $73K | — | Filing → |
| PBYI | SELL | 2023-06-15 | $76K | — | Filing → |